Free Trial

Stealth BioTherapeutics (MITO) News Today

→ Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad)
Free MITO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Headlines
Stock Analysis
May 7, 2024 | prnewswire.com
STEALTH BIOTHERAPEUTICS' BARTH SYNDROME NDA RECEIVES PRIORITY REVIEW DESIGNATION
May 6, 2024 | prnewswire.com
Stealth BioTherapeutics to Present at JMP Citizens Life Sciences Conference
April 17, 2024 | money.usnews.com
Bolt Biotherapeutics Inc
April 8, 2024 | prnewswire.com
STEALTH BIOTHERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROME
February 22, 2024 | wsj.com
Sonnet BioTherapeutics Holdings Inc.
February 9, 2024 | investing.com
Iovance Biotherapeutics Inc (IOVA)
November 23, 2023 | morningstar.com
Barinthus Biotherapeutics PLC ADR BRNS
November 17, 2023 | bizjournals.com
Lab Notes: Vittoria Biotherapeutics raises $15M; Madrigal adds to C-suite
November 16, 2023 | morningstar.com
Iovance Biotherapeutics Inc IOVA
November 9, 2023 | morningstar.com
SAB Biotherapeutics Inc SABS
October 30, 2023 | investing.com
Calidi Biotherapeutics Inc (CLDI)
September 12, 2023 | msn.com
Stealth BioTherapeutics achieves target enrolment in PMM therapy trial
September 11, 2023 | benzinga.com
Stealth BioTherapeutics Completes Target Enrollment in Global Phase 3 NuPOWER Trial in Patients with Primary Mitochondrial Myopathy
September 6, 2023 | bizjournals.com
As Needham biotech struggles with FDA, patients with an ultra-rare disease are waiting
June 2, 2023 | news.yahoo.com
B-2 stealth bombers to return to flight after 5-month delay
May 16, 2023 | dailymail.co.uk
Wealth with stealth
March 27, 2023 | marketwatch.com
Global Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (itochondrial Myopathy Diagnosis) Forecast from 2023 to 2028
February 25, 2023 | techcrunch.com
Chain Reaction raises $70M, emerges from stealth to launch chips designed to compute encrypted data
February 19, 2023 | finance.yahoo.com
Will Roper's Istari, Inc. emerges from stealth mode to transform digital engineering and accelerate Industry 4.0
November 16, 2022 | finance.yahoo.com
Stealth BioTherapeutics Corp Announces Completion of Merger
November 16, 2022 | marketbeat.com
Trading was temporarily halted for "MITO" at 07:11 PM with a stated reason of "News pending."
November 1, 2022 | finance.yahoo.com
Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
October 27, 2022 | news.yahoo.com
As Trump Org trial looms, lawyers to look out for 'stealth jurors'
October 7, 2022 | finance.yahoo.com
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
September 15, 2022 | finance.yahoo.com
Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events
August 5, 2022 | msn.com
Short Volatility Alert: Stealth BioTherapeutics Corp
August 1, 2022 | benzinga.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Stealth BioTherapeutics Corp (Nasdaq - MITO), Romeo Power, Inc. (NYSE - RMO), One Medical (Nasdaq - ONEM), Hanger, Inc. (NYSE - HNGR)
August 1, 2022 | nasdaq.com
Stealth BioTherapeutics To Be Taken Private In All-cash Deal
August 1, 2022 | finance.yahoo.com
Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction
July 26, 2022 | finance.yahoo.com
MITO: Stealth BioTherapeutics Considering Offer, While Progress Continues
June 28, 2022 | marketwatch.com
Stealth BioTherapeutics Gets Buyout Offer
June 27, 2022 | seekingalpha.com
Stealth Bio gains after non-binding buyout offer
June 27, 2022 | nasdaq.com
Stealth BioTherapeutics Board Receives Preliminary Proposal Letter
June 27, 2022 | finance.yahoo.com
Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposal
June 27, 2022 | marketbeat.com
Trading was temporarily halted for "MITO" at 06:06 AM with a stated reason of "News pending."
June 14, 2022 | markets.businessinsider.com
Stealth Granted Pre-NDA Meeting For Elamipretide To Treat Barth Syndrome
June 14, 2022 | seekingalpha.com
Stealth Bio rises on pre-NDA meeting for candidate targeting rare heart condition
June 14, 2022 | finance.yahoo.com
Stealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth Syndrome
June 8, 2022 | finance.yahoo.com
Healthcare Breakthroughs: NVAX, MITO, LMLLF, NMLSF; Life Sciences Leaders Report Latest Advances in Vaccines, Novel Therapeutics for Autism, Neurodegenerative, Oncology, and Glaucoma
June 8, 2022 | benzinga.com
Why Stealth BioTherapeutics Shares Are Surging Today?
June 8, 2022 | finance.yahoo.com
Stealth BioTherapeutics Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium
May 31, 2022 | seekingalpha.com
Stealth Bio's elamipretide gets EMA orphan drug status for muscle disorder
May 31, 2022 | finance.yahoo.com
Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Myopathic Mitochondrial DNA Depletion Syndrome
May 23, 2022 | finance.yahoo.com
Stealth BioTherapeutics Announces Data from the Phase 2 ReCLAIM-2 Study of Elamipretide in Geographic Atrophy at the Clinical Trials at the Summit Meeting 2022
May 12, 2022 | seekingalpha.com
Stealth Bio climbs on FDA’s Orphan Drug status for lead asset in muscular disorder
May 3, 2022 | msn.com
MITO: Positive Data Despite Miss for MITO
May 2, 2022 | seekingalpha.com
Stealth Bio slips as blindness trial fails to meet main goal
May 2, 2022 | finance.yahoo.com
STEALTH BIOTHERAPEUTICS ANNOUNCES DATA FROM RECLAIM-2 PHASE 2 TRIAL OF ELAMIPRETIDE IN GEOGRAPHIC ATROPHY
May 2, 2022 | marketbeat.com
Trading was temporarily halted for "MITO" at 07:05 AM with a stated reason of "News pending."
April 11, 2022 | seekingalpha.com
Stealth BioTherapeutics to raise $8.5M in equity financing
Get Stealth BioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MITO and its competitors with MarketBeat's FREE daily newsletter.

Protect Your Bank Account Before It’s Too Late (Ad)

For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …

Stop right now and do these 3 things to protect yourself

MITO Media Mentions By Week

MITO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MITO
News Sentiment
▼
0.00

0.75
▲
Average
Medical
News Sentiment

MITO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MITO Articles
This Week
▼
0

0
▲
MITO Articles
Average Week

Get Stealth BioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MITO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:MITO) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Hurry! Buy this stock before the Robinhood traders do!
Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...
Traders Agency | Sponsored
Moonshot Coins for the Current Crypto Run
Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...
Crypto 101 Media | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
Missed NVDA? Buy this AI stock NOW
After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...
Chaikin Analytics | Sponsored